Skip to content

Clinical assessment of regeneration potential with different bioactive material in young permanent teeth.

Clinical assessment of regeneration potential with NeoMTA , NeoPUTTY and Biodentine in young permanent teeth: A randomised clinical study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031557
Enrollment
30
Registered
2021-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: NEO PUTTY: Neo Putty Bioactive material 3315 W 12th St, Houston, TX 77008, United States Control Intervention1: Neo mta: Bioactive material 3315 W 12th St, Houston, TX 77008, United

Sponsors

Dr Abhinav Talekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with young permanent teeth having non-vital pulp. Patients having permanent molars with a deep carious lesion. Patients with carious teeth having spontaneous pain. Patients with H/o swelling . Patients with clinical or radiographic evidence of pulp degeneration. Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: Pateints having teeth with Vital pulp. Patients not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
There is a significant difference in the regeneration potential of young permanent teeth treated with NeoMTA , NeoPUTTY and Biodentine.Timepoint: 3 Months 6 Months 9 Months 12 Months

Secondary

MeasureTime frame
There is a significant difference in the regeneration potential of young permanent teeth treated with NeoMTA , NeoPUTTY and Biodentine. Timepoint: 3 Months 6 Months 9 Months 12 Months

Countries

India

Contacts

Public ContactDr Abhinav Talekar

MARDC PUNE

drabhinavtalekar@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026